- Grants since 2016
- 113
- Awarded, last 5 years (where amounts are published)
- AUD 36M
- Funded works, last 5 years
- 761
- Funded works, all time
- 2 658
Grants
2022–2023 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Modelling epigenetic reprogramming as immunotherapy for metastatic breast cancer
2022–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Finding My Way-Advanced: Can a web-based psychosocial intervention improve mental quality of life for women with metastatic breast cancer?
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Targeting fatty acid oxidation, a novel approach for prostate cancer treatment
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Targeting HOXA1-expressing stem cells to improve therapies for myelodysplastic syndromes
2022–2023 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Alternative splicing of Iroquois Homeobox-4 (IRX4) as a mediator of androgen signalling in aggressive prostate cancer
2022–2026 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Identifying synthetic lethal and microenvironmental targets to improve outcome of therapy-related myeloid neoplasms
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Utilising cord blood-derived natural killer cells to prevent post-transplant relapse in childhood leukaemia
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Prognostic value of pleural effusion-derived tissue resident memory T cells
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Understanding the crosstalk between autophagy and microbial lactate in stomach cancer
2022–2024 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Targeting the myeloid-specific kinase HCK in non-small cell lung cancer to improve response to therapy
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Linking gut bacteria to the development of early onset colorectal cancer using multi-omic profiling
2022–2026 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
SEAFARER – Is radiation therapy patient specific quality assurance in Australia effective?
2022–2025 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Improving safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
CaPP3 Australia: A randomised double blind dose non-inferiority trial of aspirin in Lynch syndrome with open label extension
2022–2023 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
A fatty link between stem cells and endometrial cancer: Understanding the role of Axin2+ stem cells in endometrial regeneration, cancer, and metastasis
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
Dynamic cancer targeting for radiation therapy patients
2022–2025 · research · 2021 Priority-driven Collaborative Cancer Research Scheme
An age-old problem: The role of senescent bone marrow stromal cells in MGUS to multiple myeloma progression
2021–2023 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Reprogramming the tumour microenvironment to improve immunotherapy
2021–2023 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Designing personalised treatment strategies for KEAP1-mutant lung cancer
2021–2023 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Novel targets for paediatric brain tumour immunotherapy
2021–2023 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Comprehensively identifying causal risk factors for breast cancer with applications of contemporary causation assessment methods to inform prevention and risk prediction
2021–2023 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
CCR1 as a key therapeutic target in the prevention of drug resistance and relapse in multiple myeloma
2021–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Humanized rat models - the next frontier in pre-clinical osteosarcoma research
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
A combined immuno-molecular biomarker for early breast disease
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Long-read genetic and epigenetic profiling in lung cancer for precision medicine
2021–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Immuno-metabolic biomarkers to predict treatment response in metastatic prostate cancer
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
A new gene modification strategy for generating optimised CAR-T cells for therapy of glioblastoma
Central Adelaide Local Health Network Incorporated
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Augmenting CXCR3 ligand production to enhance the trafficking of T cells in solid cancers
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
The harms and benefits of sun exposure: striking the right balance
The Council Of The Queensland Institute Of Medical Research
2021–2024 · research · 2020 Priority-driven Collaborative Cancer Research Scheme
Targeting CDk9 in lethal prostate cancer
2021–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Enhanced polyamine depletion as a novel therapy for aggressive childhood cancers
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
ASCOLT: ASpirin for Dukes C and high risk B COLorecTal cancer. An International, Multi-centre, Double Blind, Randomised Trial
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
The Preclinical Validation of Radio-labelled Girentuximab as a Theranostic Agent in Metastatic Colorectal Cancer
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Predicting and improving anti-tumour responses to immunotherapy in advanced cancer patients
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Obesity epidemic fuelling the surge of endometrial cancers: Elucidating the role and targeting of molecular signals involved in fat and endometrial cancer cross-talk
2020–2022 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
SCRIPT: an RCT of genomic-based stratified colorectal cancer screening in primary care
2020–2024 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Functional precision medicine for aggressive childhood cancers
2020–2023 · research · 2019 Priority-driven Collaborative Cancer Research Scheme
Integrative approaches to identifying the causes of familial breast cancer
2020–2021 · research · 2019 Priority-driven Collaborative Cancer Research Scheme